New Jobs Added Daily
Employment Biogen IDEC
Find Out From The Motley Fool!
Website Match
Welcome to Biogen Idec Inc. website ... Every day is a different challenge. ” JUSTIN McCUE, PhD. Senior Engineer, BioPharm Development
Biogen Idec, Inc. (NASDAQ: BIIB) is an American biotechnology company specializing in drugs for neurological disorders, autoimmune disorders and cancer. The company ...
Biogen Idec Corporate ... A biotechnology pioneer. Biogen Idec helped create an industry that has touched countless lives.
Join a great company! ... Looking for an inspirational career? Explore the wide variety of career opportunities at Biogen Idec and discover how you can contribute to ...
View the basic BIIB stock chart on Yahoo! Finance. Change the date range, chart type and compare Biogen Idec Inc. against other companies.
New Data Presented at 64th AAN Annual Meeting Highlights Biogen Idec's Commitment to Deliver Promising Therapies for Unmet Needs in Neurodegenerative Diseases
Stock analysis for Biogen Idec Inc (BIIB:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Biogen Idec has offices in 30 countries around the world. Corporate HQ International HQ Argentina Australia Austria Brazil Czech Republic
Biogen Idec and Isis Pharmaceuticals Announce Global Collaboration for Antisense Program Targeting Spinal Muscular Atrophy--
WESTON, Mass.---- Today Biogen Idec announced that detailed positive data from CONFIRM, the second Phase 3 clinical trial of oral BG-12 in people with
